Novotech is a multi-award winning contract research organization (CRO). Founded in 1996, we’re headquartered in Australia, and have offices in Sydney, Brisbane and Melbourne, and across the Asia-Pacific region, including China, Hong Kong, India, Malaysia, New Zealand, Philippines, Singapore, South Korea, Taiwan and Thailand. We’re internationally recognized in the industry as a leading regional full-service CRO, with services including clinical trials, biostatistics, data management, regulatory affairs, audits and medical writing.
Location: New Zealand, Auckland
Employees: 1001-5000
Phone: +61 2 8569 1400
Total raised: $220K
Valuation: $2.3B
Founded date: 1996
Investors 2
| Date | Name | Website |
| - | TPG | tpg.com |
| - | Mercury Ca... | mercurycap... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.01.2020 | - | $220K | - |
Mentions in press and media 19
| Date | Title | Description |
| 30.01.2026 | Primmune Therapeutics: $8.6 Million Raised For Cclinical Development Of PRTX007 | Primmune Therapeutics announced it has completed an additional $8.6 million close of its Series B financing, bringing the total amount raised in the round to $23.3 million. The latest close included participation from Bioqube Ventures, Ober... |
| 29.12.2025 | Unlocking Real-World Evidence: 5 Questions to Ask Before Trusting AI-Curated RWD | Aracelis Torres, PhD, MPH, SVP of Data & Science at Verana Health In today’s pharmaceutical industry, real-world evidence (RWE) offers significant potential across all phases of the product life cycle, from trial design to product launc... |
| 03.07.2025 | Novotech Earns Frost & Sullivan's 2025 Global Company of the Year Recognition for Excellence in Biotech Clinical Research Services | Recognized for its biotech-first focus, innovation in clinical trial delivery, and best-in-class client experience, Novotech sets the global standard in contract research for biotechs and small- mid-size pharma companies. SAN ANTONIO, July ... |
| 28.06.2025 | Frost & Sullivan Recognizes Leading Organizations with Prestigious 2025 Best Practices Awards | Frost & Sullivan celebrates companies for their outstanding achievements at the Frost & Sullivan Best Practices Awards Gala SAN ANTONIO, June 28, 2025 /PRNewswire/ -- The best in business gathered in Los Angeles, California, at the ... |
| 31.03.2025 | Novotech Receives Investment From GIC, Temasek, and TPG | Novotech, a Sydney, Australia-based biotech specialist clinical research organization (CRO), received an investment from GIC, Teasek and TPG. The amount of the deal was not disclosed. The company intends to use the funds to accelerate its g... |
| 25.07.2024 | ObvioHealth announces strategic investment by Guardant Health to accelerate deployment of oncology clinical trials globally | SINGAPORE, July 25, 2024 /PRNewswire/ -- ObvioHealth, a global digital clinical trials company, announces a new strategic investment by Guardant Health, Inc., a leading precision oncology company offering liquid and tissue biopsy tests acro... |
| 13.03.2024 | Novotech Publishes Precision Oncology Landscape Whitepaper Identifying Current Trends and Opportunities in Targeted Therapies | BOSTON, March 12, 2024 (GLOBE NEWSWIRE) -- Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase,... |
| 12.03.2024 | Novotech publie un rapport complet sur la myopathie de Duchenne en soutien à l’avancée de la recherche biotechnologique | BOSTON, 12 mars 2024 (GLOBE NEWSWIRE) -- Novotech L’organisation internationale de recherche clinique sous contrat (ou ORC) proposant une gamme complète de services, et axée sur le développement de partenariats avec des sociétés de biotechn... |
| 12.03.2024 | Novotech 发布杜氏肌营养不良症前景报告支持生物技术研究计划 | 波士顿, March 13, 2024 (GLOBE NEWSWIRE) -- Novotech提供全球全方位服务，与生物技术公司合作加速各阶段进阶和新颖疗法开发的临床合同研究组织 (CRO)，今天发布行业领先的杜氏肌营养不良症临床试验前景报告。 报告包括新兴基因疗法、资金形式和一份 SWOT 分析，旨在为战略性药物开发决策提供信息，并最终提高 DMD 治疗成功的机会和影响力。Novotech 研究分析师团队每月提供此类专家报告，且报告完全免费。这些报告提供了全球临床试验活动... |
| 12.03.2024 | Novotech veröffentlicht Bericht über Behandlungslandschaft bei Duchenne-Muskeldystrophie zur Unterstützung der Forschungsplanung im Bereich der Biotechnologie | BOSTON, March 12, 2024 (GLOBE NEWSWIRE) -- Novotech, das globale klinische Auftragsforschungsinstitut (Clinical Research Organization, CRO) mit umfassendem Service, das mit Biotech-Unternehmen zusammenarbeitet, um die Entwicklung fortschrit... |
Show more